Lamivudine oral sol.10mg/ml/BOT-100ml

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Lamivudine oral solution 10mg/ml, bottle pack of 100ml with oral dispensing device

Technical Specifications:
Each 1ml oral solution contains 10mg of Lamivudine. Pack comes with oral dispensing device

Therapeutic class:
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI)

Standard shelf life:
24 months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and


WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Packaging and storage:
Store below 30ºC.
Keep out of reach and sight of children.
Note: Use solution within 1 (one) month after opening.

Dispensing instructions:
Dispense in original container. Do not repack

Regulatory Status
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items